The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
27876250 |
60 |
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH |
Jagiellonian University Medical College |
27480029 |
6 |
Exploring new scaffolds for angiotensin II receptor antagonism. |
National Hellenic Research Foundation |
26824643 |
69 |
Mimicking of Arginine by Functionalized N(¿)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples. |
University of Regensburg |
26988801 |
55 |
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents. |
Jagiellonian University Medical College |
25699147 |
6 |
Interconversion of Functional Activity by Minor Structural Alterations in Nonpeptide AT2 Receptor Ligands. |
Uppsala University |
25313325 |
8 |
Saralasin and Sarile Are AT2 Receptor Agonists. |
Universit£ |
25254961 |
32 |
Optimized protein kinase C¿ (PKC¿) inhibitors reveal only modest anti-inflammatory efficacy in a rodent model of arthritis. |
Abbvie Bioresearch Center |
24625069 |
28 |
Structure-activity relationship studies toward the discovery of selective apelin receptor agonists. |
University of Strasburg |
23265881 |
49 |
Design, synthesis, and evaluation of imidazo[4,5-c]pyridin-4-one derivatives with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-¿. |
Pfizer |
19757839 |
26 |
The replacement of His(4) in angiotensin IV by conformationally constrained residues provides highly potent and selective analogues. |
Vrije Universiteit Brussel |
21413808 |
170 |
Synopsis of some recent tactical application of bioisosteres in drug design. |
Bristol-Myers Squibb Pharmaceutical Research and Development |
22931505 |
69 |
Chemokine receptor antagonists. |
National Heart and Lung Institute |
23010269 |
145 |
Discovery of 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate (ML221) as a functional antagonist of the apelin (APJ) receptor. |
Sanford-Burnham Medical Research Institute |
22889560 |
16 |
The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: a concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivatives. |
University of Patras |
22727371 |
22 |
Design, synthesis and biological activity of 6-substituted carbamoyl benzimidazoles as new nonpeptidic angiotensin II AT1 receptor antagonists. |
School of Chemical Engineering & The Environment |
22750010 |
30 |
Synthesis and biological evaluation of 4'-[(benzimidazole-1-yl)methyl]biphenyl-2-sulfonamide derivatives as dual angiotensin II/endothelin A receptor antagonists. |
China Pharmaceutical University |
20875743 |
90 |
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: design, synthesis, and structure-activity rela |
Pfizer |
20493713 |
30 |
Selective angiotensin II AT(2) receptor agonists with reduced CYP 450 inhibition. |
Uppsala University |
16220969 |
219 |
Designed multiple ligands. An emerging drug discovery paradigm. |
Organon Laboratories |
12773029 |
8 |
Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites. |
Technische Universit£T Darmstadt |
8576904 |
78 |
Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy. |
Dupont Pharmaceuticals |
8709104 |
10 |
Novel cyclic analogs of angiotensin II with cyclization between positions 5 and 7: conformational and biological implications. |
Washington University |
22309912 |
28 |
Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists. |
Beijing Institute of Technology |
21683484 |
8 |
Application of Ullmann and Ullmann-Finkelstein reactions for the synthesis of N-aryl-N-(1H-pyrazol-3-yl) acetamide or N-(1-aryl-1H-pyrazol-3-yl) acetamide derivatives and pharmacological evaluation. |
University of Lille |
21557540 |
39 |
Discovery of a series of imidazo[4,5-b]pyridines with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-¿. |
Pfizer |
21071232 |
78 |
Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists--a perspective. |
The M. S. University of Baroda |
20813948 |
63 |
Spiroindolones, a potent compound class for the treatment of malaria. |
Swiss Tropical and Public Health Institute |
20591666 |
66 |
A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase. |
Università |
20146480 |
8 |
The amino-terminus of angiotensin II contacts several ectodomains of the angiotensin II receptor AT1. |
Universite De Sherbrooke |
20079636 |
78 |
Synthesis and biological activities of novel indole derivatives as potent and selective PPARgamma modulators. |
Glaxosmithkline |
| 60 |
The SAR of 6-(N-alkyl-N-acyl)-2-propyl-3-[(2′-tetrazol-5-yl)biphen-4-yl)methyl]-quinazolinones as balanced affinity antagonists of the human AT1 and AT2 receptors |
TBA |
| 3 |
D and L-N-[(1-benzyl-1H-imidazol-5-yl)-alkyl]-amino acids as angiotensin II AT-1 antagonists |
TBA |
| 56 |
Potent triazolinone-based angiotensin II receptor antagonists with equivalent affinity for both the AT1 and AT2 subtypes |
TBA |
| 134 |
Development of angiotensin II antagonists with equipotent affinity for human AT1 and AT2 receptor subtypes. |
TBA |
| 122 |
Balanced angiotensin II receptor antagonists. III. The effects of substitution at the imidazole 5-position. |
TBA |
| 68 |
Balanced angiotensin II receptor antagonists. II.1,2 4-aminomethyl- and acylaminomethylimidazoles |
TBA |
| 19 |
Imidazolinones as nonpeptide angiotensin II receptor antagonists |
TBA |
| 11 |
Valsartan, a potent, orally active angiotensin II antagonist developed from the structurally new amino acid series |
TBA |
| 12 |
A potent long-acting imidazole-5-acrylic acid angiotensin II AT-1 receptor antagonist |
TBA |
14761190 |
10 |
Recognition of privileged structures by G-protein coupled receptors. |
Novo Nordisk |
12361407 |
4 |
Comparison of 3D structures and AT(1) binding properties of pyrazolidine-3,5-diones and tetrahydropyridazine-3,6-diones with parent antihypertensive drug irbesartan. |
Université |
12190306 |
14 |
Discovery of N-isoxazolyl biphenylsulfonamides as potent dual angiotensin II and endothelin A receptor antagonists. |
Bristol-Myers Squibb Pharmaceutical Research Institute |
12113820 |
4 |
Novel human metabolites of the angiotensin-II antagonist tasosartan and their pharmacological effects. |
Wyeth Research |
31948845 |
126 |
Identification of potent pyrazole based APELIN receptor (APJ) agonists. |
Rti International |
10893306 |
21 |
Synthesis and pharmacological evaluation of new pyrazolidine-3, 5-diones as AT(1) angiotensin II receptor antagonists. |
Université |
29939744 |
179 |
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential. |
Shanghaitech University |
32030982 |
14 |
The Other Angiotensin II Receptor: AT |
Centre Hospitalier Universitaire Vaudois (Chuv) and University of Lausanne (Unil |
31009912 |
5 |
Multitarget PPAR? agonists as innovative modulators of the metabolic syndrome. |
University of Chieti "G. D.Annunzio |
30594432 |
30 |
Identification of BR101549 as a lead candidate of non-TZD PPAR? agonist for the treatment of type 2 diabetes: Proof-of-concept evaluation and SAR. |
Boryung Pharmaceuticals |
31083946 |
2 |
Hydroxyl Groups in Synthetic and Natural-Product-Derived Therapeutics: A Perspective on a Common Functional Group. |
University of Basel |
30655952 |
89 |
Discovery of TD-0212, an Orally Active Dual Pharmacology AT |
Theravance Biopharma Us |
26565745 |
165 |
Benzazaborinines as Novel Bioisosteric Replacements of Naphthalene: Propranolol as an Example. |
Janssen Pharmaceutica |
26397395 |
43 |
Discovery of novel, potent and low-toxicity angiotensin II receptor type 1 (AT1) blockers: Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazoles with a chiral center. |
Beijing Institute of Technology |
24200932 |
2 |
Design, synthesis, and biological evaluation of 1,2,4-triazole bearing 5-substituted biphenyl-2-sulfonamide derivatives as potential antihypertensive candidates. |
China Pharmaceutical University |
24007859 |
33 |
Nonpeptidic angiotensin II AT? receptor antagonists derived from 6-substituted aminocarbonyl and acylamino benzimidazoles. |
Beijing Institute of Technology |
23376252 |
13 |
Rational design, efficient syntheses and biological evaluation of N,N'-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers. |
University of Patras |
7629811 |
19 |
Novel angiotensin II receptor antagonists. Design, synthesis, and in vitro evaluation of dibenzo[a,d]cycloheptene and dibenzo[b,f]oxepin derivatives. Searching for bioisosteres of biphenylyltetrazole using a three-dimensional search technique. |
Shionogi |
7562905 |
258 |
Potent and orally active angiotensin II receptor antagonists with equal affinity for human AT1 and AT2 subtypes. |
Merck Research Laboratories |
18386881 |
38 |
Beta-homo-amino acid scan of angiotensin IV. |
Vrije Universiteit Brussel |
29969256 |
21 |
Fibrogenic Disorders in Human Diseases: From Inflammation to Organ Dysfunction. |
Universitaire Vaudois |
30177375 |
16 |
Discovery of the bifunctional modulator of angiotensin II type 1 receptor (AT1R) and PPAR? derived from the AT1R antagonist, Fimasartan. |
Boryung Pharmaceuticals |
29329002 |
5 |
Integration of multi-scale molecular modeling approaches with experiments for the in silico guided design and discovery of novel hERG-Neutral antihypertensive oxazalone and imidazolone derivatives and analysis of their potential restrictive effects on cell proliferation. |
Bahcesehir University (Bau) |
29631962 |
252 |
Identification and biological evaluation of thiazole-based inverse agonists of ROR?t. |
Phenex Pharmaceuticals |
24129576 |
4 |
High accuracy in silico sulfotransferase models. |
Albert Einstein College of Medicine |
26833890 |
18 |
Synthesis, Biological Evaluation, and Molecular Docking of 8-imino-2-oxo-2H,8H-pyrano[2,3-f]chromene Analogs: New Dual AChE Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease. |
Yogi Vemana University |
26469307 |
7 |
Phosphorylation of Capsaicinoid Derivatives Provides Highly Potent and Selective Inhibitors of the Transcription Factor STAT5b. |
University of Leipzig |
24641677 |
65 |
1,3-disubstituted-4-aminopyrazolo [3, 4-d] pyrimidines, a new class of potent inhibitors for phospholipase D. |
University of Massachusetts Boston |